Global Enteric Disease Testing and Therapeutic Market Size, Status and Forecast 2019-2025

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Enteric Disease Testing and Therapeutic Revenue
• 1.4 Market by Type
  • 1.4.1 Global Enteric Disease Testing and Therapeutic Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Bacterial disease
  • 1.4.3 Viral disease
  • 1.4.4 Parasitic diseases
• 1.5 Market by Application
  • 1.5.1 Global Enteric Disease Testing and Therapeutic Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospital
  • 1.5.3 Research
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Enteric Disease Testing and Therapeutic Market Perspective (2015-2026)
• 2.2 Global Enteric Disease Testing and Therapeutic Growth Trends by Regions
  • 2.2.1 Enteric Disease Testing and Therapeutic Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Enteric Disease Testing and Therapeutic Historic Market Share by Regions (2015-2020)
  • 2.2.3 Enteric Disease Testing and Therapeutic Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Enteric Disease Testing and Therapeutic Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Enteric Disease Testing and Therapeutic Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Enteric Disease Testing and Therapeutic Players by Market Size
  • 3.1.1 Global Top Enteric Disease Testing and Therapeutic Players by Revenue (2015-2020)
  • 3.1.2 Global Enteric Disease Testing and Therapeutic Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Enteric Disease Testing and Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Enteric Disease Testing and Therapeutic Market Concentration Ratio
  • 3.2.1 Global Enteric Disease Testing and Therapeutic Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Enteric Disease Testing and Therapeutic Revenue in 2019
• 3.3 Enteric Disease Testing and Therapeutic Key Players Head office and Area Served
• 3.4 Key Players Enteric Disease Testing and Therapeutic Product Solution and Service
• 3.5 Date of Enter into Enteric Disease Testing and Therapeutic Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Enteric Disease Testing and Therapeutic Historic Market Size by Type (2015-2020)
• 4.2 Global Enteric Disease Testing and Therapeutic Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Enteric Disease Testing and Therapeutic Market Size by Application (2015-2020)
• 5.2 Global Enteric Disease Testing and Therapeutic Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Enteric Disease Testing and Therapeutic Market Size (2015-2020)
• 6.2 Enteric Disease Testing and Therapeutic Key Players in North America (2019-2020)
• 6.3 North America Enteric Disease Testing and Therapeutic Market Size by Type (2015-2020)
• 6.4 North America Enteric Disease Testing and Therapeutic Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Enteric Disease Testing and Therapeutic Market Size (2015-2020)
• 7.2 Enteric Disease Testing and Therapeutic Key Players in Europe (2019-2020)
• 7.3 Europe Enteric Disease Testing and Therapeutic Market Size by Type (2015-2020)
• 7.4 Europe Enteric Disease Testing and Therapeutic Market Size by Application (2015-2020)

8 China

• 8.1 China Enteric Disease Testing and Therapeutic Market Size (2015-2020)
• 8.2 Enteric Disease Testing and Therapeutic Key Players in China (2019-2020)
• 8.3 China Enteric Disease Testing and Therapeutic Market Size by Type (2015-2020)
• 8.4 China Enteric Disease Testing and Therapeutic Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Enteric Disease Testing and Therapeutic Market Size (2015-2020)
• 9.2 Enteric Disease Testing and Therapeutic Key Players in Japan (2019-2020)
• 9.3 Japan Enteric Disease Testing and Therapeutic Market Size by Type (2015-2020)
• 9.4 Japan Enteric Disease Testing and Therapeutic Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Enteric Disease Testing and Therapeutic Market Size (2015-2020)
• 10.2 Enteric Disease Testing and Therapeutic Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Enteric Disease Testing and Therapeutic Market Size by Type (2015-2020)
• 10.4 Southeast Asia Enteric Disease Testing and Therapeutic Market Size by Application (2015-2020)

11 India

• 11.1 India Enteric Disease Testing and Therapeutic Market Size (2015-2020)
• 11.2 Enteric Disease Testing and Therapeutic Key Players in India (2019-2020)
• 11.3 India Enteric Disease Testing and Therapeutic Market Size by Type (2015-2020)
• 11.4 India Enteric Disease Testing and Therapeutic Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Enteric Disease Testing and Therapeutic Market Size (2015-2020)
• 12.2 Enteric Disease Testing and Therapeutic Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Enteric Disease Testing and Therapeutic Market Size by Type (2015-2020)
• 12.4 Central & South America Enteric Disease Testing and Therapeutic Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Abbott
  • 13.1.1 Abbott Company Details
  • 13.1.2 Abbott Business Overview
  • 13.1.3 Abbott Enteric Disease Testing and Therapeutic Introduction
  • 13.1.4 Abbott Revenue in Enteric Disease Testing and Therapeutic Business (2015-2020))
  • 13.1.5 Abbott Recent Development
• 13.2 GlaxoSmithKline
  • 13.2.1 GlaxoSmithKline Company Details
  • 13.2.2 GlaxoSmithKline Business Overview
  • 13.2.3 GlaxoSmithKline Enteric Disease Testing and Therapeutic Introduction
  • 13.2.4 GlaxoSmithKline Revenue in Enteric Disease Testing and Therapeutic Business (2015-2020)
  • 13.2.5 GlaxoSmithKline Recent Development
• 13.3 Becton Dickinson
  • 13.3.1 Becton Dickinson Company Details
  • 13.3.2 Becton Dickinson Business Overview
  • 13.3.3 Becton Dickinson Enteric Disease Testing and Therapeutic Introduction
  • 13.3.4 Becton Dickinson Revenue in Enteric Disease Testing and Therapeutic Business (2015-2020)
  • 13.3.5 Becton Dickinson Recent Development
• 13.4 bioMérieux
  • 13.4.1 bioMérieux Company Details
  • 13.4.2 bioMérieux Business Overview
  • 13.4.3 bioMérieux Enteric Disease Testing and Therapeutic Introduction
  • 13.4.4 bioMérieux Revenue in Enteric Disease Testing and Therapeutic Business (2015-2020)
  • 13.4.5 bioMérieux Recent Development
• 13.5 Sanofi
  • 13.5.1 Sanofi Company Details
  • 13.5.2 Sanofi Business Overview
  • 13.5.3 Sanofi Enteric Disease Testing and Therapeutic Introduction
  • 13.5.4 Sanofi Revenue in Enteric Disease Testing and Therapeutic Business (2015-2020)
  • 13.5.5 Sanofi Recent Development
• 13.6 Bayer Pharma
  • 13.6.1 Bayer Pharma Company Details
  • 13.6.2 Bayer Pharma Business Overview
  • 13.6.3 Bayer Pharma Enteric Disease Testing and Therapeutic Introduction
  • 13.6.4 Bayer Pharma Revenue in Enteric Disease Testing and Therapeutic Business (2015-2020)
  • 13.6.5 Bayer Pharma Recent Development
• 13.7 Bio-Rad
  • 13.7.1 Bio-Rad Company Details
  • 13.7.2 Bio-Rad Business Overview
  • 13.7.3 Bio-Rad Enteric Disease Testing and Therapeutic Introduction
  • 13.7.4 Bio-Rad Revenue in Enteric Disease Testing and Therapeutic Business (2015-2020)
  • 13.7.5 Bio-Rad Recent Development
• 13.8 Quest Diagnostics
  • 13.8.1 Quest Diagnostics Company Details
  • 13.8.2 Quest Diagnostics Business Overview
  • 13.8.3 Quest Diagnostics Enteric Disease Testing and Therapeutic Introduction
  • 13.8.4 Quest Diagnostics Revenue in Enteric Disease Testing and Therapeutic Business (2015-2020)
  • 13.8.5 Quest Diagnostics Recent Development
• 13.9 Trinity Biotech
  • 13.9.1 Trinity Biotech Company Details
  • 13.9.2 Trinity Biotech Business Overview
  • 13.9.3 Trinity Biotech Enteric Disease Testing and Therapeutic Introduction
  • 13.9.4 Trinity Biotech Revenue in Enteric Disease Testing and Therapeutic Business (2015-2020)
  • 13.9.5 Trinity Biotech Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer